» Authors » Toshinari Odawara

Toshinari Odawara

Explore the profile of Toshinari Odawara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 442
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ide K, Asami T, Suda A, Yoshimi A, Fujita J, Shiraishi Y, et al.
PLoS One . 2022 Nov; 17(11):e0277174. PMID: 36355760
The COVID-19 pandemic has been affecting the mental health of hospital workers. During the prolonged pandemic, hospital workers may experience much more severe psychological distress, leading to an increased risk...
2.
Sugaya N, Tomita Y, Funaba M, Iida H, Shirotsuki K, Gardner F, et al.
Biopsychosoc Med . 2022 Jul; 16(1):15. PMID: 35871011
Background: The Cognitive Scale for Functional Bowel Disorders (CS-FBD) and Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ) are a useful measures to assess cognitive-behavioral aspects in individuals with IBS. This study...
3.
Odawara T, Hasegawa K, Kajiwara R, Takeuchi H, Tagawa M, Kosaka K, et al.
Am J Geriatr Psychiatry . 2021 Aug; 30(3):314-328. PMID: 34420834
Objectives: To evaluate the long-term efficacy and safety of zonisamide, an antiepileptic agent, in dementia with Lewy bodies (DLB). Design: Phase three clinical trial with 12 week, randomized, placebo-controlled, double-blind,...
4.
Ide K, Asami T, Suda A, Yoshimi A, Fujita J, Nomoto M, et al.
PLoS One . 2021 Jan; 16(1):e0245294. PMID: 33428676
The aim of the present study was to investigate the psychological effects of the COVID-19 outbreak and associated factors on hospital workers at the beginning of the outbreak with a...
5.
Hasegawa K, Kochi K, Maruyama H, Konishi O, Toya S, Odawara T
J Alzheimers Dis . 2020 Dec; 79(2):627-637. PMID: 33337365
Background: Although previous phase II and III clinical trials conducted in Japan showed that zonisamide improved parkinsonism in patients with dementia with Lewy bodies (DLB), some differences in efficacy outcomes...
6.
Murata M, Odawara T, Hasegawa K, Kajiwara R, Takeuchi H, Tagawa M, et al.
Parkinsonism Relat Disord . 2020 Jan; 76:91-97. PMID: 31982288
Introduction: Zonisamide is approved in Japan for treating motor dysfunction in Parkinson's disease, and might also be effective for parkinsonism in patients with dementia with Lewy bodies (DLB). Our study...
7.
Manabe Y, Odawara T, Konishi O
Psychogeriatrics . 2019 Feb; 19(4):345-354. PMID: 30784148
Background: We performed a questionnaire survey of medical doctors engaged in the management of dementia to identify the actual status of treatment for dementia with Lewy bodies (DLB) in Japan....
8.
Odawara T, Manabe Y, Konishi O
Psychogeriatrics . 2019 Feb; 19(4):310-319. PMID: 30723980
Background: Dementia with Lewy bodies (DLB) is a progressive form of dementia, accompanied by a range of behavioural and psychological symptoms. The aim of this study was to identify current...
9.
Murata M, Odawara T, Hasegawa K, Iiyama S, Nakamura M, Tagawa M, et al.
Neurology . 2018 Jan; 90(8):e664-e672. PMID: 29367449
Objective: To investigate the efficacy and safety of zonisamide as an adjunct to levodopa therapy for parkinsonism in patients with dementia with Lewy bodies (DLB). Methods: This phase 2, placebo-controlled,...
10.
Kaneta T, Katsuse O, Hirano T, Ogawa M, Shihikura-Hino A, Yoshida K, et al.
BMC Neurol . 2017 May; 17(1):91. PMID: 28506213
Background: To analyze voxel-wise correlation between cerebral blood flow (CBF) measured using ASL-MRI and cognition in patients with Alzheimer's disease (AD). Methods: Forty-one patients diagnosed with AD or mild cognitive...